Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinomaGanesan Ramamoorthi, Brian J. Czerniecki, Colin Snyder et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 26